In conclusion, we show here that cytotoxicity of AdV-TRAIL can be enhanced in TRAIL-resistant and TRAIL-sensitive melanoma cells by co-silencing of the antiapoptotic Bcl-2 protein Mcl-1 by activation of apoptosis and necrosis. The gene discussed is TNFSF10; the disease is melanoma.